eular textbook on rheumatic diseases 23 - module 20.pdf  eular textbook on rheumatic diseases...

Download EULAR Textbook on Rheumatic Diseases 23 - module 20.pdf  EULAR Textbook on Rheumatic Diseases References

Post on 04-Aug-2018

232 views

Category:

Documents

3 download

Embed Size (px)

TRANSCRIPT

  • EULAR Textbook on Rheumatic Diseases

    References chapter 23

    1. Preliminary criteria for the classification of systemic sclerosis (scleroderma).

    Subcommittee for scleroderma criteria of the American Rheumatism Association

    Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23(5):581-90.

    2. Poormoghim H, Lucas M, Fertig N, Medsger TA, Jr. Systemic sclerosis sine

    scleroderma: demographic, clinical, and serologic features and survival in forty-eight

    patients. Arthritis Rheum 2000;43(2):444-51.

    3. Mayes MD, Lacey JV, Jr., Beebe-Dimmer J, Gillespie BW, Cooper B, Laing

    TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic

    sclerosis in a large US population. Arthritis Rheum 2003;48(8):2246-55.

    4. Czirjak L, Kiss CG, Lovei C, Suto G, Varju C, Fuzesi Z, et al. Survey of

    Raynaud's phenomenon and systemic sclerosis based on a representative study of

    10,000 south-Transdanubian Hungarian inhabitants. Clin Exp Rheumatol

    2005;23(6):801-8.

    5. Allcock RJ, Forrest I, Corris PA, Crook PR, Griffiths ID. A study of the prevalence

    of systemic sclerosis in northeast England. Rheumatology (Oxford) 2004;43(5):596-602.

    6. Kettaneh A, Al Moufti O, Tiev KP, Chayet C, Toledano C, Fabre B, et al.

    Occupational exposure to solvents and gender-related risk of systemic sclerosis: a

    metaanalysis of case-control studies. J Rheumatol 2007;34(1):97-103.

    7. Bovenzi M, Barbone F, Pisa FE, Betta A, Romeo L, Tonello A, et al. A case-

    control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ

    Health 2004;77(1):10-6.

    8. Mayes MD. Epidemiologic studies of environmental agents and systemic

    autoimmune diseases. Environ Health Perspect 1999;107 Suppl 5:743-8.

    9. Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S, et al. Systemic

    sclerosis and occupational risk factors: a case-control study. Occup Environ Med

    2002;59(8):545-9.

    10. Garabrant DH, Lacey JV, Jr., Laing TJ, Gillespie BW, Mayes MD, Cooper BC, et

    al. Scleroderma and solvent exposure among women. Am J Epidemiol 2003;157(6):493-

    500.

  • EULAR Textbook on Rheumatic Diseases 11. Jimenez SA, Artlett CM. Microchimerism and systemic sclerosis. Curr Opin

    Rheumatol 2005;17(1):86-90.

    12. Hamamdzic D, Kasman LM, LeRoy EC. The role of infectious agents in the

    pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2002;14(6):694-8.

    13. Herrick AL, Matucci Cerinic M. The emerging problem of oxidative stress and the

    role of antioxidants in systemic sclerosis. Clin Exp Rheumatol 2001;19(1):4-8.

    14. Johnson RW, Tew MB, Arnett FC. The genetics of systemic sclerosis. Curr

    Rheumatol Rep 2002;4(2):99-107.

    15. Allanore Y, Dieude P, Boileau C. Updating the genetics of systemic sclerosis.

    Curr Opin Rheumatol.

    16. Jungel A, Ospelt C, Gay S. What can we learn from epigenetics in the year

    2009? Curr Opin Rheumatol;22(3):284-92.

    17. Derk CT, Jimenez SA. Systemic sclerosis: current views of its pathogenesis.

    Autoimmun Rev 2003;2(4):181-91.

    18. Neidhart M, Kuchen S, Distler O, Bruhlmann P, Michel BA, Gay RE, et al.

    Increased serum levels of antibodies against human cytomegalovirus and prevalence of

    autoantibodies in systemic sclerosis. Arthritis Rheum 1999;42(2):389-92.

    19. Jimenez SA, Diaz A, Khalili K. Retroviruses and the pathogenesis of systemic

    sclerosis. Int Rev Immunol 1995;12(2-4):159-75.

    20. Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin

    lesions from women with systemic sclerosis. N Engl J Med 1998;338(17):1186-91.

    21. Artlett CM. Microchimerism and scleroderma: an update. Curr Rheumatol Rep

    2003;5(2):154-9.

    22. Nelson JL. Microchimerism and HLA relationships of pregnancy: implications for

    autoimmune diseases. Curr Rheumatol Rep 2001;3(3):222-9.

    23. LeRoy EC. Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am

    1996;22(4):675-94.

    24. Renaudineau Y, Revelen R, Levy Y, Salojin K, Gilburg B, Shoenfeld Y, et al.

    Anti-endothelial cell antibodies in systemic sclerosis. Clin Diagn Lab Immunol

    1999;6(2):156-60.

    25. Kahaleh B. Lymphocyte interactions with the vascular endothelium in systemic

    sclerosis. Clin Dermatol 1994;12(3):361-7.

  • EULAR Textbook on Rheumatic Diseases 26. Kahaleh MB. Vascular involvement in systemic sclerosis (SSc). Clin Exp

    Rheumatol 2004;22(3 Suppl 33):S19-23.

    27. Gruschwitz MS, Hornstein OP, von Den Driesch P. Correlation of soluble

    adhesion molecules in the peripheral blood of scleroderma patients with their in situ

    expression and with disease activity. Arthritis Rheum 1995;38(2):184-9.

    28. Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S. Soluble adhesion molecules

    (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in

    patients with systemic sclerosis: relationship to organ systemic involvement. Clin

    Rheumatol 2005;24(2):111-6.

    29. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy

    assessment of microvascular damage in systemic sclerosis. J Rheumatol

    2000;27(1):155-60.

    30. Allanore Y, Batteux F, Avouac J, Assous N, Weill B, Kahan A. Levels of

    circulating endothelial progenitor cells in systemic sclerosis. Clin Exp Rheumatol

    2007;25(1):60-6.

    31. Avouac J, Juin F, Wipff J, Couraud PO, Chiocchia G, Kahan A, et al. Circulating

    endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann

    Rheum Dis 2008;67(10):1455-60.

    32. Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, et al. Bone

    marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum

    2006;54(8):2605-15.

    33. Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, et al. Impairment

    of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells:

    new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum

    2007;56(6):1994-2004.

    34. Butler AR, Flitney FW, Williams DL. NO, nitrosonium ions, nitroxide ions,

    nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol Sci

    1995;16(1):18-22.

    35. Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MI.

    Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and

    systemic sclerosis. J Rheumatol 1994;21(8):1477-83.

    36. Avouac J, Borderie D, Ekindjian OG, Kahan A, Allanore Y. High DNA oxidative

    damage in systemic sclerosis. J Rheumatol;37(12):2540-7.

  • EULAR Textbook on Rheumatic Diseases 37. Ogawa F, Shimizu K, Hara T, Muroi E, Hasegawa M, Takehara K, et al. Serum

    levels of heat shock protein 70, a biomarker of cellular stress, are elevated in patients

    with systemic sclerosis: association with fibrosis and vascular damage. Clin Exp

    Rheumatol 2008;26(4):659-62.

    38. Ogawa F, Shimizu K, Hara T, Muroi E, Komura K, Takenaka M, et al.

    Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide

    reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular

    damage. Arch Dermatol Res;302(1):27-35.

    39. Farina GA, York MR, Di Marzio M, Collins CA, Meller S, Homey B, et al. Poly(I:C)

    drives type I IFN- and TGFbeta-mediated inflammation and dermal fibrosis simulating

    altered gene expression in systemic sclerosis. J Invest Dermatol;130(11):2583-93.

    40. Kraling BM, Maul GG, Jimenez SA. Mononuclear cellular infiltrates in clinically

    involved skin from patients with systemic sclerosis of recent onset predominantly consist

    of monocytes/macrophages. Pathobiology 1995;63(1):48-56.

    41. Chizzolini C. T lymphocyte and fibroblast interactions: the case of skin

    involvement in systemic sclerosis and other examples. Springer Semin Immunopathol

    1999;21(4):431-50.

    42. Sakkas LI, Xu B, Artlett CM, Lu S, Jimenez SA, Platsoucas CD. Oligoclonal T cell

    expansion in the skin of patients with systemic sclerosis. J Immunol 2002;168(7):3649-

    59.

    43. Radstake TR, van Bon L, Broen J, Wenink M, Santegoets K, Deng Y, et al.

    Increased frequency and compromised function of T regulatory cells in systemic

    sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS ONE

    2009;4(6):e5981.

    44. Klein S, Kretz CC, Ruland V, Stumpf C, Haust M, Hartschuh W, et al. Reduction

    of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic

    scleroderma. Ann Rheum Dis.

    45. Avouac J, Furnrohr BG, Tomcik M, Palumbo K, Zerr P, Horn A, et al.

    Inactivation of the transcription factor STAT-4 prevents inflammation-driven

    fibrosis in animal models of systemic sclerosis. Arthritis Rheum;63(3):800-9.

    46. Fenoglio D, Battaglia F, Parodi A, Stringara S, Negrini S, Panico N, et al.

    Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with

    systemic sclerosis. Clin Immunol.

  • EULAR Textbook on Rheumatic Diseases 47. Fujimoto M, Sato S. B lymphocytes and systemic sclerosis. Curr Opin Rheumatol

    2005;17(6):746-51.

    48. Lafyatis R, O'Hara C, Feghali-Bostwick CA, Matteson E. B cell infiltration in

    systemic sclerosis-associated interstitial lung disease. Arthritis Rheum 2007;56(9):3167-

    8.

    49. Fujimoto M, Sato S. B cell signaling and autoimmune diseases: C

Recommended

View more >